This case broadens the phenotypic spectrum associated with <i>MAP1B</i> syndrome, suggesting that elimination disorder, frequently reported in FXS, should also be evaluated in <i>MAP1B</i> pathogenic variant carriers. This evidence concerns the gene MAP1B and Down syndrome.